Related Experiment Video
Updated: Feb 15, 2026
13:57
Bio-layer Interferometry for Measuring Kinetics of Protein-protein Interactions and Allosteric Ligand Effects
Published on: February 18, 2014
30.4K
Anti-leukemic effects of PPARγ ligands
Somi Ryu1, Dae Seong Kim2, Myoung Woo Lee2
1Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Jinju, South Korea.
Cancer Letters
|January 15, 2018
Summary
Peroxisome proliferator-activated receptor (PPAR) gamma ligands show promise for treating leukemia by inducing apoptosis and inhibiting cancer cell growth. Further research is needed to understand their mechanisms for clinical application.
Area of Science:
- Molecular Biology
- Oncology
- Pharmacology
Background:
- Peroxisome proliferator-activated receptor (PPAR) gamma is a nuclear receptor involved in various diseases, including cancer.
- Current leukemia therapies have limitations in effectiveness and safety.
- PPAR gamma ligands represent a novel therapeutic class for hematologic malignancies.
Purpose of the Study:
- To review existing studies on the anti-leukemic effects of PPAR gamma ligands.
- To elucidate the mechanisms and molecules underlying the anti-leukemic activity of PPAR gamma ligands.
- To identify potential therapeutic applications of PPAR gamma ligands in leukemia treatment.
Main Methods:
- Literature review of preclinical and clinical studies.
- Analysis of molecular mechanisms, including apoptosis induction, proliferation inhibition, and differentiation promotion.
- Identification of specific PPAR gamma ligands with anti-leukemic properties.
Main Results:
- PPAR gamma ligands demonstrate significant anti-leukemic effects in various studies.
- These ligands can induce apoptosis, inhibit proliferation, and promote differentiation of leukemia cells.
- Several PPAR gamma ligands with identified anti-leukemic effects have been reported.
Conclusions:
- PPAR gamma ligands hold substantial therapeutic potential for leukemia.
- A deeper understanding of their specific mechanisms is crucial for clinical development.
- Further research and clinical trials are warranted to fully evaluate PPAR gamma ligands as anti-leukemic agents.
Related Concept Videos
02:40Ligand Binding Sites
15.3K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
15.3K
02:40Ligand Binding Sites
8.9K
8.9K
02:51Metal-Ligand Bonds
24.5K
The hemoglobin in the blood, the chlorophyll in green plants, vitamin B-12, and the catalyst used in the manufacture of polyethylene all contain coordination compounds. Ions of the metals, especially the transition metals, are likely to form complexes.
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
24.5K
00:49Ligand Binding and Linkage
5.7K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.7K
00:49Ligand Binding and Linkage
4.2K
4.2K
00:43Complexometric Titration: Ligands
2.4K
Different monodentate and polydentate ligands are used as complexing agents in complexometric titration reactions. The formation of complexes by mono- and bidentate ligands involves two or more intermediate steps, limiting their use as complexing agents. In comparison, polydentate ligands can form complexes with metal ions in a single-step process, facilitating sharper end points. This means polydentate ligands, such as amino carboxylic acid derivatives, are most commonly employed in...
2.4K